Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Reed

Showing results (161-170 of 263) with videos related to

Pageof 27
Sort By:
Frontiers in Immunology|March 9, 2018
Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza InfectionSusan L Baldwin, Fan-Chi Hsu, Neal Van Hoeven, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 13, 2013
Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosisMark T Orr, Christopher B Fox, Susan L Baldwin, et al.
Vaccine|August 10, 2017
Broadened immunity and protective responses with emulsion-adjuvanted H5 COBRA-VLP vaccinesJames D Allen, Simon O Owino, Donald M Carter, et al.
Infectious Diseases of Poverty|February 7, 2017
The influence of innate and adaptative immune responses on the differential clinical outcomes of leprosyAdriana Barbosa de Lima Fonseca, Marise do Vale Simon, Rodrigo Anselmo Cazzaniga, et al.
NPJ Vaccines|January 10, 2024
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccineZachary MacMillen, Kiara Hatzakis, Adrian Simpson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2004
Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant proteinYasir A W Skeiky, Mark R Alderson, Pamela J Ovendale, et al.
Diagnostic Microbiology and Infectious Disease|August 3, 2015
Alterations to antigen-specific immune responses before and after multidrug therapy of leprosyAline Araújo Freitas, Regiane Morillas Oliveira, Emerith Mayra Hungria, et al.
Vaccine|December 12, 2012
Development and pre-clinical assessment of a 73 kD chimeric fusion protein as a defined sub-unit vaccine for leprosyMalcolm S Duthie, Lucas H Sampaio, Regiane M Oliveira, et al.
European Journal of Immunology|May 30, 2013
MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvantMark T Orr, Malcolm S Duthie, Hillarie Plessner Windish, et al.
The American Journal of Tropical Medicine and Hygiene|May 11, 2016
An rK28-Based Immunoenzymatic Assay for the Diagnosis of Canine Visceral Leishmaniasis in Latin AmericaMarta Alicia Lauricella, Cristina Graciela Maidana, Victoria Fragueiro Frias, et al.
Pageof 27

Showing results (161-170 of 263) with videos related to

Sort By:
Pageof 27
Frontiers in Immunology|March 9, 2018
Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza InfectionSusan L Baldwin, Fan-Chi Hsu, Neal Van Hoeven, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 13, 2013
Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosisMark T Orr, Christopher B Fox, Susan L Baldwin, et al.
Vaccine|August 10, 2017
Broadened immunity and protective responses with emulsion-adjuvanted H5 COBRA-VLP vaccinesJames D Allen, Simon O Owino, Donald M Carter, et al.
Infectious Diseases of Poverty|February 7, 2017
The influence of innate and adaptative immune responses on the differential clinical outcomes of leprosyAdriana Barbosa de Lima Fonseca, Marise do Vale Simon, Rodrigo Anselmo Cazzaniga, et al.
NPJ Vaccines|January 10, 2024
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccineZachary MacMillen, Kiara Hatzakis, Adrian Simpson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2004
Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant proteinYasir A W Skeiky, Mark R Alderson, Pamela J Ovendale, et al.
Diagnostic Microbiology and Infectious Disease|August 3, 2015
Alterations to antigen-specific immune responses before and after multidrug therapy of leprosyAline Araújo Freitas, Regiane Morillas Oliveira, Emerith Mayra Hungria, et al.
Vaccine|December 12, 2012
Development and pre-clinical assessment of a 73 kD chimeric fusion protein as a defined sub-unit vaccine for leprosyMalcolm S Duthie, Lucas H Sampaio, Regiane M Oliveira, et al.
European Journal of Immunology|May 30, 2013
MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvantMark T Orr, Malcolm S Duthie, Hillarie Plessner Windish, et al.
The American Journal of Tropical Medicine and Hygiene|May 11, 2016
An rK28-Based Immunoenzymatic Assay for the Diagnosis of Canine Visceral Leishmaniasis in Latin AmericaMarta Alicia Lauricella, Cristina Graciela Maidana, Victoria Fragueiro Frias, et al.
Pageof 27